Paroxysmal Nocturnal Hemoglobinuria Pipeline Review, H2 2016 - Research and Markets
Rheumatoid Arthritis Forecast in 17 Major Markets 2016-2026 - Research and Markets
Pfizer to Present New Data on XELJANZ® (Tofacitinib Citrate) for Ulcerative Colitis at UEG Week 2016
FDA Grants Breakthrough Therapy Designation for Genentech’s Actemra® (Tocilizumab) in Giant Cell Arteritis, a Form of Vasculitis
There is a small number of high-quality industrials-sector ETFs from which to choose.
A look back at the winners and losers of the final quarter of a tumultuous year.
The author does not own any of the stocks or funds mentioned above.
Most mutual fund managers do not focus on aftertax performance, but astute investors may be able to improve their aftertax returns.